2016
DOI: 10.1177/0269881116658992
|View full text |Cite
|
Sign up to set email alerts
|

The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder

Abstract: The abnormal behaviour of NK1R-/- mice (locomotor hyperactivity, inattentiveness and impulsivity in the 5-Choice Serial Reaction-Time Test) is arguably analogous to that of patients with attention deficit hyperactivity disorder (ADHD). Evidence suggests that small body size and increased body weight are risk factors for ADHD. Here, we compared the body size, body mass and body composition of male and female NK1R-/- mice and their wildtypes that had been fed either standard laboratory chow or a high-fat (45%: ‘… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 51 publications
0
4
0
Order By: Relevance
“…A focus upon sex driving diversity in drug response is also evident from the literature: Recent examples include that airway smooth muscle, isolated from obese females, manifests greater agonist‐induced excitation–contraction coupling than those derived from lean males, females, or from obese males (Orfanos et al, 2018) and that sex differences in the thermoregulatory and behavioural responses to the CNS stimulant, cathinone (Alsufyani & Docherty, 2017), have been identified. However, a notable complication is that the response of interest can depend on an interaction between sex and genotype, as was the case for the vulnerability to obesity in a strain of genetically altered mice (Pillidge, Heal, & Stanford, 2016).…”
Section: Evidence For Sex Differences That Affect Pharmacologymentioning
confidence: 99%
“…A focus upon sex driving diversity in drug response is also evident from the literature: Recent examples include that airway smooth muscle, isolated from obese females, manifests greater agonist‐induced excitation–contraction coupling than those derived from lean males, females, or from obese males (Orfanos et al, 2018) and that sex differences in the thermoregulatory and behavioural responses to the CNS stimulant, cathinone (Alsufyani & Docherty, 2017), have been identified. However, a notable complication is that the response of interest can depend on an interaction between sex and genotype, as was the case for the vulnerability to obesity in a strain of genetically altered mice (Pillidge, Heal, & Stanford, 2016).…”
Section: Evidence For Sex Differences That Affect Pharmacologymentioning
confidence: 99%
“…This gene has already been associated with psychiatric disorders such as anxiety (Muñoz and Coveñas 2014 ) and addiction (Schank 2014 ). However, in animal models this gene increases the risk of high BMI, which is at odds with AN presentation (Pillidge et al 2016 ). Therefore it remains unclear as to what, if any role, tachykinin signaling may play in AN etiology.…”
Section: Resultsmentioning
confidence: 99%
“…While TACR1 has been implicated in a variety of animal models that recapitulate core phenotypes of AN such as heightened anxiety and hyperactivity, 78 , 86 , 87 absence of TACR1 also increases risk for high body mass index in a sex-dependent manner in mice. 88 Conversely, increased TACR1 expression in human females with AN presumably increases risk for low body mass index. Among its diverse biological roles, TACR1 antagonists have been developed to treat emesis and reduction in food intake in those receiving cisplatin chemotherapy.…”
Section: Discussionmentioning
confidence: 99%